Implantable biosensors allow real-time monitoring for earlier sepsis detection in surgical patients.

• Continuous tracking of inflammatory biomarkers enhances timely diagnosis.
• New technologies achieve remarkable sensitivity for detecting cytokines and endotoxins.

Surgeons may shift from reactive to predictive management, significantly reducing sepsis-related complications.

• Global research emphasizes the potential widespread adoption across various surgical specialties.